| Ìî÷åêàìåííàÿ áîëåçíü (N20-N23) | |
| Êàìíè ïî÷êè è ìî÷åòî÷íèêà | |
| ÁËÅÌÀÐÅÍ | ESPARMA GmbH |
| ÊÀÍÅÔÐÎÍ® Í | BIONORICA AG |
| ÖÈÑÒÎÍ | HIMALAYA DRUG Co |
| Êàìíè íèæíèõ îòäåëîâ ìî÷åâûõ ïóòåé | |
| ÁËÅÌÀÐÅÍ | ESPARMA GmbH |
| ÊÀÍÅÔÐÎÍ® Í | BIONORICA AG |
| ÖÈÑÒÎÍ | HIMALAYA DRUG Co |
| Ïî÷å÷íàÿ êîëèêà íåóòî÷íåííàÿ | |
| ÁÓÑÊÎÏÀÍ | BOEHRINGER INGELHEIM FRANCE |
| ÂÎËÜÒÀÐÅÍ | NOVARTIS PHARMA AG |
| ÃÀËÈÄÎÐ | EGIS PHARMACEUTICALS Ltd. |
| ÄÈÊËÎÔÅÍÀÊ-ÀÊÎÑ | ÑÈÍÒÅÇ ÎÀÎ |
| ÍÎ-ØÏÀ | CHINOIN |
| ÐÅÂÀËÃÈÍ | SHREYA LIFE SCIENCES Pvt.Ltd. |
| ÑÏÀÇÌÀËÃÎÍ | PHARMACHIM HOLDING EAD/SOPHARMA AD |
| ÒÅÌÏÀËÃÈÍ | PHARMACHIM HOLDING EAD/SOPHARMA AD |